>
Switch to:

Tekla Life Sciences Investors Equity-to-Asset

: 1.00 (As of Sep. 2020)
View and export this data going back to . Start your Free Trial

Equity to Asset ratio is calculated as shareholder's tangible equity divided by its total asset. Tekla Life Sciences Investors's Total Stockholders Equity for the quarter that ended in Sep. 2020 was $483.6 Mil. Tekla Life Sciences Investors's Total Assets for the quarter that ended in Sep. 2020 was $484.2 Mil. Therefore, Tekla Life Sciences Investors's Equity to Asset Ratio for the quarter that ended in Sep. 2020 was 1.00.

NYSE:HQL' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.99   Med: 1   Max: 1
Current: 1

0.99
1

During the past 4 years, the highest Equity to Asset Ratio of Tekla Life Sciences Investors was 1.00. The lowest was 0.99. And the median was 1.00.

NYSE:HQL's Equity-to-Asset is ranked higher than
100% of the 1667 Companies
in the Asset Management industry.

( Industry Median: 0.82 vs. NYSE:HQL: 1.00 )

Tekla Life Sciences Investors Equity-to-Asset Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Tekla Life Sciences Investors Annual Data
Sep17 Sep18 Sep19 Sep20
Equity-to-Asset 1.00 0.99 0.99 1.00

Tekla Life Sciences Investors Semi-Annual Data
Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20
Equity-to-Asset Premium Member Only Premium Member Only 0.99 1.00 0.99 1.00 1.00

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Tekla Life Sciences Investors Equity-to-Asset Distribution

* The bar in red indicates where Tekla Life Sciences Investors's Equity-to-Asset falls into.



Tekla Life Sciences Investors Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing shareholder's tangible equity divided by its total asset.

Tekla Life Sciences Investors's Equity to Asset Ratio for the fiscal year that ended in Sep. 2020 is calculated as

Equity to Asset (A: Sep. 2020 )=Total Stockholders Equity/Total Assets
=483.57/484.166
=1.00

Tekla Life Sciences Investors's Equity to Asset Ratio for the quarter that ended in Sep. 2020 is calculated as

Equity to Asset (Q: Sep. 2020 )=Total Stockholders Equity/Total Assets
=483.57/484.166
=1.00

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Tekla Life Sciences Investors  (NYSE:HQL) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Tekla Life Sciences Investors Equity-to-Asset Related Terms


Tekla Life Sciences Investors Equity-to-Asset Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)